198823-22-2 Usage
General Description
1-Propanol, 3-[[1-(phenylmethyl)-4-piperidinyl]amino]- is a chemical compound with a molecular formula C16H24N2O. It is a derivative of propanol with an amino group attached to a piperidine ring and a phenylmethyl group. 1-Propanol, 3-[[1-(phenylmethyl)-4-piperidinyl]amino]- has potential biological activities and is commonly used as an intermediate in the synthesis of pharmaceuticals and other organic compounds. It may also have applications in the field of medicinal chemistry and drug development due to its structural features and potential pharmacological properties. Further research and studies are needed to fully understand the characteristics and potential uses of this chemical.
Check Digit Verification of cas no
The CAS Registry Mumber 198823-22-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,9,8,8,2 and 3 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 198823-22:
(8*1)+(7*9)+(6*8)+(5*8)+(4*2)+(3*3)+(2*2)+(1*2)=182
182 % 10 = 2
So 198823-22-2 is a valid CAS Registry Number.
198823-22-2Relevant articles and documents
Pharmaceutical compositions based on anticholinergics and additional active ingredients
-
, (2008/06/13)
A pharmaceutical composition comprising an anticholinergic and at least one additional active ingredient selected from among corticosteroids, dopamine agonistes, PDE-IV inhibitors, NK1-antagonists, endothelin antagonists, antihistamines, and EGFR-kinase inhibitors, processes for preparing them and their use in the treatment of respiratory diseases.
Method for the treatment or prevention of atopic dermatitis
-
, (2008/06/13)
The invention relates to a method for the treatment or prevention of atopic dermatitis, which comprises the administration of an effective amount of an NK-1 receptor antagonist to a patient in need of such treatment, wherein said NK1 receptor antagonist i
Pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists
-
, (2008/06/13)
The present invention relates to novel pharmaceutical compositions based on anticholinergics and NK1-receptor antagonists, processes for preparing them and their use in the treatment of respiratory tract diseases.
